Thank you, Jamie. Please turn to Slide 7, and I’ll provide an overview of the GAAP financial results for our fiscal third quarter. Revenue was $72.6 million, an increase of approximately 1% year-over-year and up approximately 3% from the prior quarter. Bookings for the quarter were slightly better than our expectations as we continue to convert recent customer wins into realized sales. Backlog also began to normalize and finished the quarter at approximately $9.3 million, which is at our target run rate of $8 million to $10 million, even though supply chain lead times still remain extended in certain areas. Our GAAP gross margin for the period expanded 320 basis points to 43.8% from 40.6% in the year ago quarter and 230 basis points from 41.5% in the prior quarter. The increase in gross margin reflects our ongoing efforts to drive improved product mix towards our higher-margin, higher-value solutions, combined with stronger royalty revenue in the quarter. GAAP net loss for the third quarter was $71.4 million, which included a non-cash charge of a negative $61.6 million related to the fair market value of warrant liabilities resulting from the significant increase in our stock price during the quarter as well as a positive non-cash impact of $1.2 million intercompany foreign currency adjustment. This compares GAAP net loss of $9.9 million or a loss of $2.08 per share in the prior fiscal quarter. Now turning to Slide 8 for non-GAAP metrics. Non-GAAP operating expenses were $30.1 million in the third quarter, an approximate 6% reduction from the $32 million last year and down approximately 1% from the prior quarter. This continued reduction in operating expenses is the result of our proactive self-help actions to improve process and productivity, and we expect to maintain operating costs at or below these levels in the fourth quarter as ongoing cost containment actions take hold. Adjusted EBITDA in the third quarter was a positive $4.7 million compared with a negative $2.6 million in the prior year third quarter and a negative $0.3 million in the prior quarter. This represents a $7.3 million improvement year-over-year and a $5 million improvement sequentially, reflects the benefits of higher quality of revenue mix combined with our ongoing operational improvements. As mentioned last quarter, and it’s worth reiterating again, our total savings from our operational initiatives have resulted in almost $40 million of savings since the end of FY ‘23. In addition to our focus on improving EBITDA and total profitability, we also continue to prioritize annual recurring revenue, which we expect to be a key driver for delivering increasing profitability over time. Moving to Slide 9. I want to briefly highlight our annual recurring revenue and subscription metrics and the progress we are making towards driving higher quality revenue. Total annual recurring revenue, or ARR, for the trailing 12 months was approximately 49% of our total revenue at $141 million, with a gross margin on the combined business being approximately 67%. As a company, we continue to focus on our total subscription TCV and subscription ARR by maximizing our quantum subscription opportunities to both our partners and customers globally. This quarter, we have another positive indicator that demonstrates our progress on subscription ARR with the third quarter increasing approximately 29% year-over-year and approximately 9% sequentially to $21.3 million with over 90% of new unit sales in the quarter being subscription-based. Continuing this rotation and focus on total recurring revenue is a key element of our long-term business model and driving increased profitability and cash flow. Now please turn to Slide 10 for an overview of the debt and liquidity at the end of the quarter. Cash, cash equivalents and restricted cash at the end of the third quarter were approximately $20.6 million. Outstanding debt split between term and our revolver was $105.9 million and $37.5 million, respectively. As of the quarter end, the company’s net debt position was $133 million. Turning to Slide 11. As Jamie previously mentioned, one of our highest strategic priorities has been to improve the company’s overall cost structure, including significant reduction in our outstanding debt. Quantum has made substantial efforts over the last year to improve our operational and financial health through a combination of revenue and margin improvement plans, financial and organizational restructuring and cost reduction initiatives. We have been exploring several alternatives to pay down our current outstanding debt, which would also help to lower our cost structure, including lowering the interest expense and other fees the company has incurred. These actions, combined with improving our operating free cash flow, strengthen Quantum for its future success. Subsequent to quarter end, we announced a standby equity purchase agreement with Yorkville Advisors as a strategic financial partner. This agreement gives Quantum the right to access additional capital at the company’s discretion over a 3-year period. As part of the agreement, the initial tranche is limited to 1.15 million shares or 19.99% of outstanding shares, with the remainder requiring shareholder approval. In support of Quantum’s effort to strengthen our balance sheet, the company’s existing lenders have provided covenant forbearance for both fiscal Q3 2025 and fiscal Q4 2025. As we work towards shareholder approval. Turning to Slide 12. Let me close out the company’s guidance for the fiscal fourth quarter and an updated view of fiscal 2025 overall. First, we are reiterating our previously full year financial revenue guidance of $280 million, plus or minus $5 million, which contemplates fourth quarter total revenue of approximately $66 million, plus or minus $2 million. The fiscal fourth quarter primarily reflects the normal calendar first quarter seasonality, potential impact from supply chain headwinds that may occur. We expect to hold fourth quarter non-GAAP operating expenses effectively flat at $30 million, plus or minus $1 million, reflecting the significant cost reduction actions we have taken over the last 2 years. As a result, non-GAAP adjusted net loss per share for the fourth quarter is expected to be a negative $1.16, plus or minus $0.05 per share based on an estimated 5.8 million shares outstanding. Our outlook for the full year adjusted EBITDA continues to be $3 million, plus or minus $1 million, which contemplates fourth quarter adjusted EBITDA of approximately $1.7 million. The midpoint of our EBITDA guidance represents a significant year-over-year improvement of approximately $8 million, both on a quarterly and on a full year basis. With that, I’ll now hand the call back to Jamie for closing remarks.